01.09.2023 - NEW YORK and SAN DIEGO, Sept. 01, 2023 (GLOBE NEWSWIRE) - Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting .